Johns Hopkins University: Multiple Sclerosis, Relapsing-Remitting trials

The registry lists 10 Multiple Sclerosis, Relapsing-Remitting studies with Johns Hopkins University as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 3Phase 3 2Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple SclerosisTerminatedNCT04767698Phase 2Results posted
• Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple SclerosisCompletedNCT04261790Phase 4Results posted
• Intranasal Insulin for Improving Cognitive Function in Multiple SclerosisCompletedNCT02988401Phase 1/2Results posted
• Pharmacokinetics of Vitamin D in Multiple Sclerosis and in HealthCompletedNCT01667796Not applicableResults posted
• Vitamin D Supplementation in Multiple SclerosisCompletedNCT01490502Phase 3Results posted
• Traditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialCompletedNCT03500328Not applicable
• A Pilot Study of Intermittent Calorie Restriction in Multiple SclerosisCompletedNCT02647502Not applicable
• Open-label Study of Liothyronine in MSCompletedNCT02506751Phase 1
• Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple SclerosisWithdrawnNCT01337427Phase 3
• High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple SclerosisWithdrawnNCT00939549Phase 2